Cruz, P.d.l.C.; Muñoz, A.M.; Ávila, E.G.G.; Piña, O.E.H.; Urizar, J.T.P.
Bioequivalence of Two Empagliflozin 25 mg Immediate-Release Tablet Formulations Under Fasting Conditions in Healthy Mexican Subjects. Pharmaceuticals 2026, 19, 842.
https://doi.org/10.3390/ph19060842
AMA Style
Cruz PdlC, Muñoz AM, Ávila EGG, Piña OEH, Urizar JTP.
Bioequivalence of Two Empagliflozin 25 mg Immediate-Release Tablet Formulations Under Fasting Conditions in Healthy Mexican Subjects. Pharmaceuticals. 2026; 19(6):842.
https://doi.org/10.3390/ph19060842
Chicago/Turabian Style
Cruz, Porfirio de la Cruz, Alberto Martínez Muñoz, Erika Gabriela Guido Ávila, Omar Emmanuel Hernández Piña, and José Trinidad Pérez Urizar.
2026. "Bioequivalence of Two Empagliflozin 25 mg Immediate-Release Tablet Formulations Under Fasting Conditions in Healthy Mexican Subjects" Pharmaceuticals 19, no. 6: 842.
https://doi.org/10.3390/ph19060842
APA Style
Cruz, P. d. l. C., Muñoz, A. M., Ávila, E. G. G., Piña, O. E. H., & Urizar, J. T. P.
(2026). Bioequivalence of Two Empagliflozin 25 mg Immediate-Release Tablet Formulations Under Fasting Conditions in Healthy Mexican Subjects. Pharmaceuticals, 19(6), 842.
https://doi.org/10.3390/ph19060842